This new york times article was quite worthy of thinking about. In particular, it's still not clear to me that C-reactive protein is the best possible marker of high cardiovascular risk. Nor, if the primary mechanism is inflammation, why conventional anti-inflammatory medications like aspirin are not the best therpuetic choice. Statins also lower blood pressure but they are clearly not the best anti-hypertensive medication option for healthy, low risk patients.
It is a pretty large public health experiment and I can only hope that the benefits will exceed any potential side effects of medication use.
No comments:
Post a Comment